Safety, pharmacokinetics, and preliminary efficacy of isatuximab in patients awaiting kidney transplantation

Trial Identifier: TED16414
Sponsor: sanofi
Start Date: June 2020
Primary Completion Date: May 2022
Study Completion Date: May 2022
Condition: Immune, Inflammatory & Infections - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Spain, Barcelona [Barcelona] Barcelona, Barcelona [Barcelona], Spain, 08035
Spain, Catalunya [Cataluña] Hospitalet de Llobregat, Catalunya [Cataluña], Spain, 08907
United States, California San Francisco, California, United States, 94143
United States, Minnesota Rochester, Minnesota, United States, 55905
United States, New York New York, United States, 10016
United States, Texas Houston, Texas, United States, 77030